Telmisartan (40 mg) + Cilnidipine (10 mg) + Chlorthalidone (12.5 mg) is a triple-action antihypertensive combination used for the effective management of moderate to severe hypertension (high blood pressure). This formulation works through three complementary mechanisms to provide better and sustained blood pressure control.
Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and prevents narrowing of arteries. Cilnidipine, a calcium channel blocker, helps widen blood vessels and improves blood flow by reducing the pressure exerted on arterial walls. Chlorthalidone is a thiazide-like diuretic that removes excess salt and water from the body, reducing fluid volume and lowering blood pressure.
Together, this combination helps maintain stable blood pressure levels, reduces strain on the heart, and lowers the risk of cardiovascular complications such as heart attack, stroke, and kidney damage.
Indications
Management of moderate to severe hypertension
Uncontrolled high blood pressure with single or dual therapy
Helps reduce risk of heart attack and stroke
Prevention of hypertension-related kidney damage
Used in patients requiring multi-drug BP control
Helpful in fluid retention associated with hypertension
